These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6814877)

  • 1. Possible effect of drugs on arterial wall metabolism in experimental atherosclerosis.
    Mrhová O; Urbanová D
    Czech Med; 1982; 5(3):165-75. PubMed ID: 6814877
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pyridinolcarbamate on enzyme changes in the arterial wall of rats intoxicated with allylamine.
    Mrhová O; Shimamoto T; Numano F
    Biochem Pharmacol; 1975 Mar; 24(5):567-70. PubMed ID: 1125060
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperreactive arterial endothelial cells in atherogenesis. Effect of smooth muscle relaxants.
    Shimamoto T; Moriya K; Kobayashi DV; Takahashi T; Numano F
    Adv Exp Med Biol; 1977; 82():234-6. PubMed ID: 920366
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of pyridinolcarbamate on serum and vascular wall lipids in the rabbit].
    Sanmald R; Wagener H; Schlierf G; Dornbusch T; Sann E
    Verh Dtsch Ges Inn Med; 1972; 78():1230-2. PubMed ID: 4665504
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of phthalazinol (EG 626) and pyridinolcarbamate (Anginin) on lipolytic enzyme activities in rat adipose tissue -in vivo and in vitro-.
    Tomita T; Yonekura I; Shirasaki Y; Hayashi E; Numano F
    Jpn J Pharmacol; 1980 Feb; 30(1):65-73. PubMed ID: 6249948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pyridinolcarbamate on lipid metabolism of normal and arteriosclerotic intima in human femoral arteries].
    Horsch AK; Gilli J; Schreiter U
    Verh Dtsch Ges Inn Med; 1974; 80():952-4. PubMed ID: 4454699
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of Mercurascan on some enzymes of striated muscle in acute and chronic stages of ischaemia.
    Mrhová O; Kolc J; Málek P
    Biochem Pharmacol; 1978 Feb; 27(3):359-60. PubMed ID: 619917
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Effect of pyridinolcarbamate on the lipid metabolism of normal and atherosclerotic intima in human femoral arteries].
    Horsch AK; Gilli J; Schreiter U
    MMW Munch Med Wochenschr; 1974 May; 116(22):1112. PubMed ID: 4211589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyridinolcarbamate in diabetic angiopathies].
    Indovina I; Furitano G; Notarbartolo A; Citarrella P; Scaffidi A
    Minerva Med; 1978 May; 69(24):1681-97. PubMed ID: 566399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in some enzyme activities of the arterial wall in post-hypophyseal hormone experimental arteriopathies].
    Magrassi F; De Martini R; Gastaldi G; Bertieri AL
    Pathologica; 1967; 59(879):503-11. PubMed ID: 4319299
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effect of pyridinolcarbamate on the vascular wall of rats with hypervitaminosis D.
    Mrhová O; Shimamoto T; Numano F
    Atherosclerosis; 1972; 16(1):1-8. PubMed ID: 4262650
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 13. Vessel wall metabolism in SHR rats in relation to atherosclerosis.
    Mrhová O; Albrecht I; Urbanová D
    Ann N Y Acad Sci; 1976; 275():302-10. PubMed ID: 1070276
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthetic studies of antiatherogenic agents. (VI) Syntheses of carbamate derivative of substituted phthalazinones (author's transl)].
    Eguchi Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1977; 11():49-53. PubMed ID: 284539
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies of parmidin (pyridinolcarbamate) effect on microvascular permeability of the lungs, skin and mesentery].
    Gorizontoba MP; Shvarts GIa
    Biull Eksp Biol Med; 1979 Sep; 88(9):272-5. PubMed ID: 519015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pyridinolcarbamate (PDC) on surface microvessels in man: preliminary findings.
    Rouen LR; Terry EN; Clauss RH; Redisch W
    Bibl Anat; 1975; 13():358-9. PubMed ID: 1231780
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid synthesis in normal and atherosclerotic human intima in vitro under the effect of pyridinolcarbamate].
    Gilli J; Horsch AK; Leyendecker I; Schreiter U
    Vasa; 1976; 5(2):88-94. PubMed ID: 973428
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to the study of the biochemical behavior of the arterial wall in aging and atherogenesis. Similarities and differences in these 2 states].
    Fontaine R; Ebel A; Pantesco V; Kempf E; Mack G
    Angiology; 1968 Mar; 19(3):172-97. PubMed ID: 4230715
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic changes in the arterial wall and endothelial injury in experimental methioninaemia.
    Mrhová O; Hladovec J; Urbanová D
    Cor Vasa; 1988; 30(1):73-9. PubMed ID: 3378448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of capillary permeability by a combination of pyridinolcarbamate and adenosine].
    Igual A; Vericat Cadesas F; Beaus R
    Arch Farmacol Toxicol; 1978 Apr; 4(1):88-9. PubMed ID: 697407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.